Evaluation of the Role of Brain Natriuretic Peptide in Acute Coronary Syndrome .
ConditionAcute Coronary Syndromes
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
The measurements of the natriuretic peptide are useful and beneficial for risk stratification irrespective of the cause during admission time or during hospital stay course. the aim of the study is to Assessment of the role of Brain natriuretic peptide in diagnosis of acute coronary syndrome . Evaluation of the relation of Brain natriuretic peptide to the severity and occurrence of complications in acute coronary syndrome .
Eligibility criteria
This trial accepts healthy volunteersQualifiers
patients with acute coronary syndrome.
Disqualifiers
Patients with previous MI
Eection fraction (EF) less than 30%
Patients having cardiomyopathy
Patients having renal, liver, malignant, infectious, or inflammatory diseases .
Trial population
patients with acute coronary syndrome.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 2 trial groupsGroup A: group 1
Group B: group 2
Trial outcomes
Primary outcomes
1
Brain natriuretic peptide level in blood
level of Brain natriuretic peptide in acute coronary syndrome patients.
Time frame
baselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: